BGM:NASDAQ, BGM Group Ltd.

BGM stock overview

BGM Group Ltd. (BGM:NASDAQ) closed at $7.85 on October 23, 2026, down 12.78% on the day. The stock trades 97.4% below its 52-week high of $302.40 and 21.7% above its 52-week low of $6.45. Over the past year, it lost 16.0%. BGM Group Ltd. is part of the Health Care sector.

Key figures

Price
$7.85
Day change
-12.78%
Volume
54,582
Average volume
6,941
Market cap
104M+
52-week range
$6.45 – $302.40
50-day average
$8.44
200-day average
$22.35

Price action over the past year

In 251 trading sessions since October 23, 2025, BGM closed higher on 107 days (43%). Its best day was June 10, 2026 (+25.00%) and its worst was February 4, 2026 (-38.08%). The stock moved 10% or more in a single session 37 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

About BGM Group Ltd.

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generate most of the revenue.

Similar stocks

Find more stocks like BGM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.